Meet our partners
Olswang LLP
Olswang is a pioneering law firm with a distinctive approach to business, and we know what's important for entrepreneurs to get right from the very beginning. Read more at

Jan 2016 Olswang advises Convergence Pharmaceuticals on its acquisition by Biogen Idec

May 2015 Olswang acts for Focus Pharmaceuticals in winning UK patent litigation case against Novartis

Feb 2015 Olswang bolsters its international intellectual property practice with four-strong team hire from Winston & Strawn

OneStart Europe Vision Film 2016

  • Stephen Reese, Partner, Olswang LLP 
  • Dan Perez, CEO & Founder, Oxbridge Biotech Roundtable 
  • Nooman Haque, Director of Life Sciences, Silicon Valley Bank
  • Richard Mason, Head of Johnson & Johnson Innovation London, Johnson & Johnson 
  • Jeanne Bolger, VP Venture Investing, Johnson & Johnson Innovation - JJDC
  • Matthew Foy, Partner, SR One
  • Sarah Haywood, CEO, MedCity 
  • Matthias Essenpreis, CTO (Diagnostics), F-Hoffman-La Roche Ltd. 
  • Rachel Moss, Associate Principal, McKinsey and Company 
  • Claire Brown, Investment Manager, Alderley Park Ventures / BioCity 
  • Lynne Murray, Partnering and Strategy, MedImmune
  • Aric Orbach, Head of Pharmacology, Teva Pharmaceutical Industries 
  • Ilan Zipkin, Investment Director, Takeda Ventures Inc. 

From the OneStart London Bootcamp 2015 


Seminar: The Cradle to Grave of Company Law - Niall McAlister, Olswang

  • Niall McAlister, Partner, Olswang
Catherine Merry
Senior Associate at Olswang LLP + more
Catherine advises on the design, implementation and operation of employee share incentive arrangements including tax efficient share plans and bespoke share and cash incentive arrangements for a wide range of companies. She has vast experience advising start-up companies on how best to incentivise their founders and employees and also assists international clients wishing to extend their employee share incentive arrangements to the UK and Europe. Catherine was a medical physicist and worked in a number of London hospitals prior to qualifying as a solicitor.
Niall McAlister
Partner - Olswang LLP + more
Niall has over twenty-five years' experience as a corporate lawyer and has a wide experience of mergers and acquisitions, joint ventures and private equity and venture capital transactions, acting for start-ups, SMEs, large corporates and institutional investors. He has particular experience representing life sciences clients, having advised both commercial entities and medical research charities on a range of transactions in the sector. He is recognised in directories for his expertise as a corporate and venture capital lawyer in the life sciences sector.
Robert Stephen
Co-Chair Life Sciences Group - Olswang LLP + more
Dr Robert Stephen, Partner and co-chair of Patent Prosecution, co-chair Life Sciences. Robert's focus is on helping his clients develop and exploit their IP to maximise company value. He has worked with a number of successful start-ups, including Kymab in Cambridge UK and Insmed in the US. Robert has experience in drafting, filing and prosecuting patent applications before the UK and EPO, patent licensing, global patent strategy, patent term extensions and portfolio management. He has been involved in over 50 EPO oppositions and appeals. Robert has a particular interest and expertise in inventions made in the fields of medical devices, pharmaceuticals, biochemistry, biotechnology, cell biology, genetics and immunology, including protein and peptide based medicines, vaccines, antibodies, nucleic acid based medicines, diagnostic methods and diagnostic apparatus.
Teams Mentored